Ontology highlight
ABSTRACT:
PROVIDER: PRJNA488113 | ENA |
REPOSITORIES: ENA
Action | DRS | |||
---|---|---|---|---|
SRR7759900.fastq.gz | Fastqsanger.gz | |||
SRR7759901.fastq.gz | Fastqsanger.gz | |||
SRR7759902.fastq.gz | Fastqsanger.gz | |||
SRR7759903.fastq.gz | Fastqsanger.gz | |||
SRR7759904.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 8 |
Hasenoehrl Erik J EJ Rae Sajorda Dannah D Berney-Meyer Linda L Johnson Samantha S Tufariello JoAnn M JM Fuhrer Tobias T Cook Gregory M GM Jacobs William R WR Berney Michael M
Nature communications 20190916 1
A major constraint for developing new anti-tuberculosis drugs is the limited number of validated targets that allow eradication of persistent infections. Here, we uncover a vulnerable component of Mycobacterium tuberculosis (Mtb) persistence metabolism, the aspartate pathway. Rapid death of threonine and homoserine auxotrophs points to a distinct susceptibility of Mtb to inhibition of this pathway. Combinatorial metabolomic and transcriptomic analysis reveals that inability to produce threonine ...[more]